Effect of purified IgGs from HIV-1-infected and non infected individuals on immune activation.

Chams, V; Biou, D; Cho, Y Y; Mbika, J P; Le Coq, H; Heshmati, F; Fouchard, M; Bizzini, B; Zagury, J F

Chams, V; Biou, D; Cho, Y Y; Mbika, J P; Le Coq, H; Heshmati, F; Fouchard, M; Bizzini, B; Zagury, J F.

Affiliation

Chams V; Laboratoire de Physiologie Cellulaire, Université P & M Curie, Paris, France.

Biomed Pharmacother ; 48(5-6): 267-72, 1994.

Article in En | MEDLINE | ID: mdl-7999989

Subject(s)

Acquired Immunodeficiency Syndrome/immunology; HIV Infections/immunology; HIV-1; Immunoglobulin G/immunology; Autoimmunity; CD4 Antigens/immunology; HIV Envelope Protein gp120/immunology; HIV Seronegativity/immunology; Humans; Immunoglobulin G/isolation & purification

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / HIV Infections / Acquired Immunodeficiency Syndrome / HIV-1 Limits: Humans Language: En Journal: Biomed Pharmacother Year: 1994 Document type: Article Affiliation country: France Country of publication: France

Search on Google

Add to My VHL

XML

PubMed Links